Objective To determine whether BRCA mutation carriers who undergo fertility treatments are
at increased risk of developing invasive epithelial ovarian cancer (IEOC). Design Historical …

Objective To evaluate the relationship between use of fertility medication (ie, selective
estrogen receptor [ER] modulator, gonadotropin, or other) or infertility treatment (ie, IVF or …

Objective: To determine whether oral contraceptive (OC) use, childbearing, breastfeeding
and tubal ligation differ between ovarian cancer cases with and without a BRCA1/2 …

Background Several of the known risk factors for ovarian cancer are thought to act through
their effects on ovulation and the menstrual cycle, such as parity, breastfeeding, and use of …

In the general population, ovarian cancer risk is inversely associated with oral contraceptive
use, tubal ligation, and childbearing. Among carriers of BRCA1 gene mutations, the data are …

Objective Despite the discovery of breast and ovarian cancer predisposition genes BRCA1
and BRCA2 more than two decades ago, almost all the available data relate to women of …

Purpose Germline mutations in BRCA genes are associated with breast and ovarian cancer
susceptibility. Because infertility is associated with breast and ovarian cancer risks, we …

OBJECTIVES: Previous studies report a survival advantage in ovarian cancer patients with
Ashkenazi Jewish (AJ) breast cancer gene (BRCA) founder mutations. The purpose of this …

Background: Several reproductive and hormonal factors are known to be associated with
ovarian cancer risk in the general population, including parity and oral contraceptive (OC) …

Background: In the general population, the risk of developing ovarian cancer is reduced in
women who have undergone tubal ligation, hysterectomy, or oophorectomy, although …